Ferrous succinate

DB14489ApprovedInvestigationalSmall molecule

Ferrous succinate is an iron supplement indicated in the treatment of iron deficiency anemia. A medication used to treat low levels of iron in the body.

Mechanism: Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Curator reviewed
Primary indication: Used in preventing and treating iron-deficiency anemia.Curator reviewed · 1 structured indication
Formula / weight: C₄H₄FeO₄ · 171.917 g/mol (avg)
Also known as: Iron succinate

Resolves to

Compound

UNII818ZYK7N91CAS10030-90-7PubChem159252

Clinical / RWD

RxNorm24946ATCB03AA06

Structure

InChIKeyMDXRFOWKIZPNTA-UHFFFAOYSA-LSMILES[Fe++].[O-]C(=O)CCC([O-])=O

Targets

P02786TFRCQ9GZT9EGLN1Q9BY41HDAC8Q9NZD4AHSPP69905HBA1Q16595FXNP02794FTH1P39748FEN1+5 more

What you can answer from here — as of April 02, 2025

13Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

129Drug interactionsStructured to mechanism, not free text

10Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

7ContraindicationsEach with its own population and attribute set

2Marketed productsAcross every region we cover

1ATC codeIncluding every combination product, plus 7 drug categories

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ferrous succinate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account